Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cost of Revenue: 2011-2012

Historic Cost of Revenue for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to $4.0 million.

  • Sonoma Pharmaceuticals' Cost of Revenue rose 13.97% to $1.1 million in Q4 2012 from the same period last year, while for Dec 2012 it was $4.8 million, marking a year-over-year increase of 32.91%. This contributed to the annual value of $4.0 million for FY2012, which is 11.54% up from last year.
  • As of FY2012, Sonoma Pharmaceuticals' Cost of Revenue stood at $4.0 million, which was up 11.54% from $3.6 million recorded in FY2011.
  • Sonoma Pharmaceuticals' 5-year Cost of Revenue high stood at $4.0 million for FY2012, and its period low was $3.6 million during FY2011.
  • Moreover, its 2-year median value for Cost of Revenue was $3.8 million (2011), whereas its average is $3.8 million.
  • Data for Sonoma Pharmaceuticals' Cost of Revenue shows a peak YoY rose of 11.54% (in 2012) over the last 5 years.
  • Yearly analysis of 2 years shows Sonoma Pharmaceuticals' Cost of Revenue stood at $3.6 million in 2011, then climbed by 11.54% to $4.0 million in 2012.